Viroptic

— THERAPEUTIC CATEGORIES —
  • Ocular infections

Viroptic Generic Name & Formulations

General Description

Trifluridine 1%; oph. soln; contains thimerosal.

Pharmacological Class

Antiviral.

How Supplied

Soln—7.5mL

Manufacturer

Viroptic Indications

Indications

Primary keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex types 1 and 2.

Viroptic Dosage and Administration

Adults and Children

<6yrs: not recommended. Do not exceed recommended dose. ≥6yrs: 1 drop every 2hrs while awake; max 9 drops/day. After reepithelialization, 1 drop every 4hrs for 7 days (at least 5 drops/day); max 21 days therapy. Reevaluate if no improvement in 7 days or incomplete reepithelialization in 14 days.

Viroptic Contraindications

Not Applicable

Viroptic Boxed Warnings

Not Applicable

Viroptic Warnings/Precautions

Warnings/Precautions

Glaucoma. Pregnancy (Cat.C). Nursing mothers.

Viroptic Pharmacokinetics

See Literature

Viroptic Interactions

Not Applicable

Viroptic Adverse Reactions

Adverse Reactions

Transient ocular burning or stinging, keratopathy, edema, irritation, keratitis sicca, hyperemia, increased intraocular pressure.

Viroptic Clinical Trials

See Literature

Viroptic Note

Not Applicable

Viroptic Patient Counseling

See Literature